Lonza Group has agreed with AstraZeneca to make AZD7442, an experimental combination of two antibodies that may be used to prevent and treat COVID-19, the Swiss contract manufacturer said on Friday.
About two years ago, security researchers James Rowley and Mark Omo got curious about a scandal in the world of electronic safes: Liberty Safe, which markets itself as “America’s #1 heavy-duty home ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback